L Wei1, C Zhang2, H Y Chen1, Z J Zhang1, Z F Ji1, T Yue3, X M Dai1, Q Zhu3, L L Ma1, D Y He3, L D Jiang4. 1. Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China. 2. Department of Orthopedics, Zhongshan Hospital of Fudan University, Shanghai, China. 3. Department of Rheumatology, Shanghai Guanghua Hospital of Integrated Chinese & Western Medicine, Shanghai, China. 4. Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: zsh-rheum@hotmail.com.
Abstract
OBJECTIVE: Dopamine receptor (DR) signaling is involved in the pathogenesis of autoimmune diseases. We aimed to measure the expression levels of DR1-5 on B cells from patients with rheumatoid arthritis (RA) and to analyze the relationship between DRs and clinical manifestations, inflammatory biomarkers, functional status and disease activity. METHODS: A total of 29 patients with RA, 12 healthy donors and 12 patients with osteoarthritis (OA) were recruited in this study. Flow cytometry was used to measure the levels of DR1-5 expressed on B cells. The relationships between B cell DR expressions and clinical features in RA patients were analyzed using the Spearman correlation test. RESULTS: The expression levels of B cell DR1-5 in both the RA and OA groups were lower than those in healthy controls. After 3 months of medication, all five receptors were elevated in RA patients, with DR2 and DR3 being significantly increased from the baseline. DR2 expression on B cells was negatively correlated with inflammatory biomarkers and disease activity. CONCLUSION: RA patients had lower expression level of DR2 on B cells compared to the healthy controls, and the level of DR2 negatively correlated with the disease activity. DR2 and DR3 might be novel predictors of patient responses to disease modifying antirheumatic drug therapy.
OBJECTIVE: Dopamine receptor (DR) signaling is involved in the pathogenesis of autoimmune diseases. We aimed to measure the expression levels of DR1-5 on B cells from patients with rheumatoid arthritis (RA) and to analyze the relationship between DRs and clinical manifestations, inflammatory biomarkers, functional status and disease activity. METHODS: A total of 29 patients with RA, 12 healthy donors and 12 patients with osteoarthritis (OA) were recruited in this study. Flow cytometry was used to measure the levels of DR1-5 expressed on B cells. The relationships between B cell DR expressions and clinical features in RApatients were analyzed using the Spearman correlation test. RESULTS: The expression levels of B cell DR1-5 in both the RA and OA groups were lower than those in healthy controls. After 3 months of medication, all five receptors were elevated in RApatients, with DR2 and DR3 being significantly increased from the baseline. DR2 expression on B cells was negatively correlated with inflammatory biomarkers and disease activity. CONCLUSION:RApatients had lower expression level of DR2 on B cells compared to the healthy controls, and the level of DR2 negatively correlated with the disease activity. DR2 and DR3 might be novel predictors of patient responses to disease modifying antirheumatic drug therapy.
Authors: Elena Schwendich; Laura Salinas Tejedor; Gernot Schmitz; Markus Rickert; Jürgen Steinmeyer; Stefan Rehart; Styliani Tsiami; Jürgen Braun; Xenofon Baraliakos; Jörg Reinders; Elena Neumann; Ulf Müller-Ladner; Silvia Capellino Journal: Cells Date: 2022-05-11 Impact factor: 7.666
Authors: Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón Journal: J Immunol Res Date: 2016-10-04 Impact factor: 4.818
Authors: L E Robledo-González; A Martínez-Martínez; V M Vargas-Muñoz; R I Acosta-González; R Plancarte-Sánchez; M Anaya-Reyes; C Fernández Del Valle-Laisequilla; J G Reyes-García; J M Jiménez-Andrade Journal: J Pain Res Date: 2017-07-27 Impact factor: 3.133